SEC
26/07/2016
On 26 July 2016 SEC S.p.A. obtained the admission of the shares on the AIM UK market organized and managed by the London Stock Exchange. The start of negotiations took place on 26 July 2016. Integræ SIM acted as a joint book-runner of the private placement. The total amount of the collection in the IPO was approximately equal to £ 3,355,182.25 entirely in a capital increase.
The placement price is equal to 151 pence. On the first negotiating day, the security traded volumes of 62,975 for an equivalent of approximately equal to £97,562
The enterprise. SEC S.p.A. is an independent agency founded in Milan in 1989, specializing mainly in public and institutional relations. Today it is present with offices in Italy and Europe.
Ultima Ricerca SEC
BREAKING NEWS| In the press release dated August 7, 2025, Litix SpA, an Innovative SME that combines art, technology, tradition, and innovation through three business units offering solutions ranging from the design and production of robotic cells for marble and other materials, to the creation of sculptures and other artistic and design works, to hardware and software development for additive manufacturing and other advanced processes, announced that its subsidiary Aivox Srl will take part, as an industrial partner, in the national research project “More4Neuro – Multi-material 3D Printing for Education in Neurosurgery.” The initiative, led by the University of Milan within the framework of the Partenariati Estesi – HealthTech program, aims to develop next-generation simulators for medical and neurosurgical training, capable of accurately replicating the tactile, mechanical, and structural properties of brain tissues through multimaterial additive manufacturing technologies. Aivox, specialized in computational design, software development, additive manufacturing, and multimaterial 3D printing, will contribute its expertise by taking responsibility for the design of physical models, definition of production processes, and validation of prototypes through iterative development and clinical testing phases. The activities assigned to Aivox have a total value of € 0.68 million, of which € 0.54 million will be covered by public funding. This project marks another step in the strategy outlined in the latest annual report, in which Litix emphasized the importance of diversifying its portfolio with highly innovative projects and strengthening its position in advanced technology markets, based on the belief that technological development and global presence are the key growth drivers in the medium term. Following a transitional year in 2024, which marked the first full year of Aivox’s operations, the participation in More4Neuro confirms the Group’s ability to seize opportunities in high-potential sectors, expanding the intersection between digital manufacturing and specialized education. Considering the information disclosed in the press release, we confirm our recommendation: Target Price € 2.50, BUY Rating and MEDIUM Risk. |
